The content discusses two new studies that have addressed concerns about the safety of benzoyl peroxide (BP)-containing acne products. Earlier this year, an independent lab had petitioned the FDA to recall these products due to finding extremely high levels of the carcinogen benzene, which can form from the decomposition of BP.
The first study compared blood benzene levels between 14 people who used BP products and 65 controls, finding no difference. The second, larger study analyzed electronic health records of over 27,000 patients using BP products and found no increased risk of blood cancers or solid tumors over 10 years, compared to a control group.
The studies were reviewed by leading dermatologists, who agreed that the findings are reassuring and that the previous report of high benzene levels due to high-temperature exposure does not have any relevant clinical significance. BP is considered the "go-to" acne treatment, and the authors advise using common sense to avoid storing products in hot environments. The FDA has not commented on the status of the citizen petition filed earlier.
翻译成其他语言
从原文生成
www.medscape.com
从中提取的关键见解
by Kathleen Doh... 在 www.medscape.com 07-22-2024
https://www.medscape.com/viewarticle/new-benzoyl-peroxide-data-reassuring-everyday-use-appears-2024a1000df1更深入的查询